The group's principal activity is to conduct research and development and limited production of niche generic and proprietary drugs from natural sources. The group extracts, isolates and purifies technology to the production and manufacture of paclitaxel. The research and development of the group is focussed primarily on antifungal, anticancer, antiviral and anti-inflammatory compounds, antiaging and memory enhancing compounds. The group also provides technical and analytical laboratory services including the testing of chemicals, cosmetics, food, household and pharmaceutical products on a contract basis. It also offers consulting services for development and pilot-plant production of pharmaceuticals for companies on a contract basis. In 2004, the group acquired ceptor inc.
